Loading
Yanuki
KEYWORD TOPIC
Lyra Therapeutics' LYR-210 Shows Positive Phase 3 Results for Chronic Rhinosinusitis | Lyra Therapeutics' LYR-210 Shows Positive Phase 3 Results for Chronic Rhinosinusitis

News / Clinical Trials

Lyra Therapeutics' LYR-210 Shows Positive Phase 3 Results for Chronic Rhinosinusitis

Lyra Therapeutics (LYRA) has announced positive results from its ENLIGHTEN 2 Phase 3 clinical trial for LYR-210, a long-acting sinonasal implant designed to treat chronic rhinosinusitis (CRS). This news led to a significant surge in Lyra's...

Breakthrough in Chronic Rhinosinusitis: Lyra's Phase 3 Trial Achieves Statistical Significance, FDA Path Ahead
Lyra Therapeutics' LYR-210 Shows Positive Phase 3 Results for Chronic Rhinosinusitis Image via Stock Titan
TOPIC lyra stock